InterventionsHumans
Glucagon-Like Peptide-1 Receptor Agonist Use Is Associated With Lower Risk Of Cardiovascular Event Recurrence Compared With Use Of Bupropion-Naltrexone or Phentermine-Topiramate: A Nationwide Target Trial Emulation Study
AHA Scientific Sessions 2025 Abstract
The paper
Wenxin Guo, M.H. Wang, Jiwon Shin, Jay B. Lusk
Show 7 more authors
Fan Li, Emily Claire O'Brien, LáShauntá M. Glover, Kristina Bortfeld, Shannon E. Aymes, Michael Porter, Brian Mac Grory,Duke University · University of North Carolina
AHA Scientific Sessions 2025 Abstract · 3 Nov 2025
Presented at AHA Scientific Sessions 2025 · Abstract 4367419
